rotenone and fisetin
rotenone has been researched along with fisetin in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Rajendran, M; Ramachandran, R | 1 |
| Awasthi, A; Corrie, L; Kapoor, B; Kaur, J; Khurana, N; Khurana, S; Khursheed, R; Kumar, R; Sharma, N; Singh, SK; Verma, S; Vyas, M | 1 |
| Awasthi, A; Dua, K; Khurana, N; Khurana, S; Khursheed, R; Kumar, R; Sharma, N; Singh, SK; Verma, S; Vishwas, S; Vyas, M | 1 |
Other Studies
4 other study(ies) available for rotenone and fisetin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Fisetin protects against rotenone-induced neurotoxicity through signaling pathway.
Topics: Antioxidants; Apoptosis; Blotting, Western; Cell Line, Tumor; Down-Regulation; Flavonoids; Flavonols; Humans; Lipid Peroxidation; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rotenone; Signal Transduction | 2019 |
Enhanced oral bioavailability and neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson's disease rat model.
Topics: Administration, Oral; Animals; Biological Availability; Disease Models, Animal; Female; Flavonols; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone | 2020 |
Improved neuroprotective activity of Fisetin through SNEDDS in ameliorating the behavioral alterations produced in rotenone-induced Parkinson's model.
Topics: Administration, Oral; Animals; Biological Availability; Emulsions; Flavonols; Nanoparticles; Particle Size; Rats; Rotenone; Solubility | 2022 |